What is it about?
In this article, industrial and clinical challenges associated with the successful translation of a nanomedicine product from preclinical to commercial stages are discussed. Further, the approaches to achieve nanomedicines clinical translation are elaborated.
Featured Image
Read the Original
This page is a summary of: Challenges Associated and Approaches for Successful Translation of Nanomedicines Into Commercial Products, Nanomedicine, March 2017, Taylor & Francis,
DOI: 10.2217/nnm-2017-0039.
You can read the full text:
Contributors
The following have contributed to this page
